Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age.

Literature DB >> 28479194

Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age.

Joy Wan¹, Nandita Mitra², Ole J Hoffstad², David J Margolis³.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2017 PMID： 28479194 PMCID： PMC5489307 DOI： 10.1016/j.anai.2017.04.003

Source DB: PubMed Journal: Ann Allergy Asthma Immunol ISSN： 1081-1206 Impact factor: 6.347

× No keyword cloud information.

9 in total

1. Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis.

Authors: David J Margolis; Brian Kim; Andrea J Apter; Jayanta Gupta; Ole Hoffstad; Maryte Papadopoulos; Nandita Mitra
Journal: JAMA Dermatol Date: 2014-03 Impact factor: 10.282

2. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.

Authors: Pei-Song Gao; Nicholas M Rafaels; Deguang Mu; Tracey Hand; Tanda Murray; Mark Boguniewicz; Tissa Hata; Lynda Schneider; Jon M Hanifin; Richard L Gallo; Li Gao; Terri H Beaty; Lisa A Beck; Donald Y M Leung; Kathleen C Barnes
Journal: J Allergy Clin Immunol Date: 2010-05-13 Impact factor: 10.793

3. Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors.

Authors: Chris Carlsten; Helen Dimich-Ward; Alexander Ferguson; Wade Watson; Roxanne Rousseau; Anne Dybuncio; Allan Becker; Moira Chan-Yeung
Journal: Ann Allergy Asthma Immunol Date: 2012-11-08 Impact factor: 6.347

4. Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood.

Authors: H Rupnik; M Rijavec; P Korošec
Journal: Br J Dermatol Date: 2015-01-06 Impact factor: 9.302

5. Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis.

Authors: Ek Greisenegger; N Novak; L Maintz; T Bieber; F Zimprich; D Haubenberger; A Gleiss; G Stingl; T Kopp; A Zimprich
Journal: J Eur Acad Dermatol Venereol Date: 2009-10-23 Impact factor: 6.166

6. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis.

Authors: Roger Kapoor; Chandrakala Menon; Ole Hoffstad; Warren Bilker; Patricia Leclerc; David J Margolis
Journal: J Am Acad Dermatol Date: 2007-08-09 Impact factor: 11.527

7. The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort.

Authors: David J Margolis; Andrea J Apter; Jayanta Gupta; Ole Hoffstad; Maryte Papadopoulos; Linda E Campbell; Aileen Sandilands; W H Irwin McLean; Tim R Rebbeck; Nandita Mitra
Journal: J Allergy Clin Immunol Date: 2012-08-27 Impact factor: 10.793

8. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up.

Authors: Evelyn X L Loo; Genevieve V Llanora; Qingshu Lu; Marion M Aw; Bee Wah Lee; Lynette P Shek
Journal: Int Arch Allergy Immunol Date: 2013-11-16 Impact factor: 2.749

Review 9. One remarkable molecule: filaggrin.

Authors: Sara J Brown; W H Irwin McLean
Journal: J Invest Dermatol Date: 2011-12-08 Impact factor: 8.551

9 in total

1. Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study.

Authors: Joy Wan; Nandita Mitra; Ole J Hoffstad; Albert C Yan; David J Margolis
Journal: J Am Acad Dermatol Date: 2019-05-11 Impact factor: 11.527

2. Association between fine mapping thymic stromal lymphopoietin and atopic dermatitis onset and persistence.

Authors: Carolyn Lou; Nandita Mitra; Bradley Wubbenhorst; Kurt D'Andrea; Ole Hoffstad; Brian S Kim; Albert Yan; Andrea L Zaenglein; Zelma Chiesa Fuxench; Katherine L Nathanson; David J Margolis
Journal: Ann Allergy Asthma Immunol Date: 2019-09-04 Impact factor: 6.347

Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age.

1. Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitis.

2. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.

3. Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors.

4. Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood.

5. Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis.

6. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis.

7. The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort.

8. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up.

Review 9. One remarkable molecule: filaggrin.

1. Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study.

2. Association between fine mapping thymic stromal lymphopoietin and atopic dermatitis onset and persistence.

3. Filaggrin gene mutations with special reference to atopic dermatitis.

Review 4. Significance of Skin Barrier Dysfunction in Atopic Dermatitis.

5. Genetics and Epigenetics of Atopic Dermatitis: An Updated Systematic Review.

6. Clinical Characteristics and Genetic Variations in Early-Onset Atopic Dermatitis Patients.

Review 7. Clinical approach to the patient with refractory atopic dermatitis.

Review 8. Atopic Dermatitis in Animals and People: An Update and Comparative Review.

9. Transcriptomic Analysis Links Eosinophilic Esophagitis and Atopic Dermatitis.